One stock whose insiders are doing some big buying is Vical (VICL), which researches and develops biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. This stock is off to a poor start in 2012, with the shares off by around 14%.
Vical has a market cap of $270.28 million and an enterprise value of $217.64 million. This stock trades at price-to-sales of 8.72, and it trades at a price-to-book of 4.06. Its estimated growth rate for this year is 74.5%, and for next year it's pegged at -176.9%. This is a cash-rich company, since the total cash position on its balance sheet is $52.63 million and its total debt is zero.A beneficial owner just bought 2.67 million shares, or $10 million worth of stock, at $3.75 per share. From a technical standpoint, VICL is currently trading above its 200-day moving average and below its 50-day moving average, which is neutral trendwise. This stock recently gapped down from over $4 a share to $3.60 on monster volume. Since that monster volume gap down, the stock has been able to hold that $3.61 low and trend a bit higher back above its 200-day moving average of $3.72. If you're bullish on VICL, I would consider getting long at current levels since the upside volume the last few days has been very strong. I would simply use a mental stop right below that recent $3.61 low, since a break of that price would have me avoiding this stock like the plague. I would only add to any long positions in VICL once it takes out its 50-day at $4.04 with volume. Look for volume that registers near or above its three-month average volume of 876,732 shares. The only reason I lean slightly bullish on VICL after that large volume gap down is that the stock is still showing a pattern of higher lows since it bottomed in October at $2.22 a share. Vical, which is rated C- hold by TheStreet Ratings, shows up on a list of the 10 Best-Performing Stocks Under $5 in 2011, along with Majesco (COOL) and Adolor (ADLR).
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV